Furthermore, emerging research suggests GLP-1 receptors exist in the brain, heart, and immune cells
Hengrui Pharmas once-daily oral GLP-1 prospect, HRS-7535, led to a mean weight loss of up to 10.9% at week 44 in a China phase 3 obesity study after excluding premature treatment discontinuations and the use of other weight-loss drugs
PubMed Sinha R, et al
Combination of metronomic cyclophosphamide and dietary intervention inhibits neuroblastoma growth in a CD1-nu mouse model
Its proposed mechanism of action includes stimulation of glucose-dependent insulin secretion, suppression of glucagon (via GLP-1), enhanced lipid metabolism (via GIP), and increased energy expenditure (via glucagon receptor activation)
Our findings show that the elevated expression of BMP-2 increased bone formation through interaction with cAMP and decreased bone resorption through RANKL inhibition in semaglutide-treated groups as shown in Fig